HIGHLIGHTS
- who: Statins- inflammation-sulforhodamine B- cisplatin- and colleagues from the (UNIVERSITY) have published the paper: Process: Submission:04/08/2022 Acceptance:12/13/2022, in the Journal: (JOURNAL)
- what: Similar to the finding with atorvastatin, most proposed statins in this work have lipophilic structure facilitating cancer cell penetration. The authors propose that it is most likely to interact with their targets through the free acidic form indicating same functional_group did bind to the same target revealing similar mechanism. Losing activity in salt Asian Pacific Journal of Cancer Prevention, Vol 23 form illuminates that the free . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.